Núria González-Rojas

781 total citations
18 papers, 553 citations indexed

About

Núria González-Rojas is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Núria González-Rojas has authored 18 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Epidemiology. Recurrent topics in Núria González-Rojas's work include Atrial Fibrillation Management and Outcomes (8 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Asthma and respiratory diseases (4 papers). Núria González-Rojas is often cited by papers focused on Atrial Fibrillation Management and Outcomes (8 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Asthma and respiratory diseases (4 papers). Núria González-Rojas collaborates with scholars based in Spain, Germany and United States. Núria González-Rojas's co-authors include José Álvarez‐Sabín, Virginia Becerra, Juan Oliva, Manuel Quintana, Javier Mar, Joan Carles Reverter, Itziar Oyagüez, José María Lobos, Antoni Martínez‐Rubio and José Ramón González‐Juanatey and has published in prestigious journals such as Stroke, Health and Quality of Life Outcomes and Respiratory Medicine.

In The Last Decade

Núria González-Rojas

17 papers receiving 540 citations

Peers

Countries citing papers authored by Núria González-Rojas

Since Specialization

Citations

This map shows the geographic impact of Núria González-Rojas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Núria González-Rojas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Núria González-Rojas more than expected).

Fields of papers citing papers by Núria González-Rojas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Núria González-Rojas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Núria González-Rojas. The network helps show where Núria González-Rojas may publish in the future.

Co-authorship network of co-authors of Núria González-Rojas

This figure shows the co-authorship network connecting the top 25 collaborators of Núria González-Rojas. A scholar is included among the top collaborators of Núria González-Rojas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Núria González-Rojas. Núria González-Rojas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Determinants of Informal Care, Burden, and Risk of Burnout in Caregivers of Stroke Survivors 2017 ·Stroke ·Juan Oliva, Luz María Peña-Longobardo, Javier Mar, (unknown), (unknown), Núria González-Rojas, Virginia Becerra, Miguel Casado, (unknown), (unknown), Manuel Quintana, José Álvarez‐Sabín	73
2	Economic impact of patients admitted to stroke units in Spain 2016 ·The European Journal of Health Economics ·(unknown), José Álvarez‐Sabín, Manuel Quintana, Jaime Masjuán, Juan Oliva, Javier Mar, Núria González-Rojas, Virginia Becerra, (unknown), (unknown)	71
3	Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting β2-agonists: a systematic review and network meta-analysis 2016 ·Therapeutic Advances in Respiratory Disease ·Max Schlueter, Núria González-Rojas, Michael Baldwin, (unknown), Florian Voß, (unknown)	44
4	Outcomes measured by mortality rates, quality of life and degree of autonomy in the first year in stroke units in Spain 2015 ·Health and Quality of Life Outcomes ·(unknown), Javier Mar, (unknown), Juan Oliva, Núria González-Rojas, Virginia Becerra, Miguel Casado, (unknown), (unknown), Manuel Quintana, José Álvarez‐Sabín	33
5	Diagnosed, undiagnosed and overall atrial fibrillation research on population over 60 year-old. AFABE study 2014 ·Josep Lluís Clua‐Espuny, Ramón Bosch, Albert Roso‐Llorach, Carlos López, (unknown), Núria González-Rojas, (unknown), (unknown), (unknown), (unknown)	2
6	Prevalence of Undiagnosed Atrial Fibrillation and of That Not Being Treated With Anticoagulant Drugs: the AFABE Study 2013 ·Revista Española de Cardiología (English Edition) ·Josep Lluís Clua‐Espuny, (unknown), Ramón Bosch, Albert Roso‐Llorach, (unknown), (unknown), Carlos López, (unknown), (unknown), Núria González-Rojas, (unknown)	42
7	Prevalencia de la fibrilación auricular desconocida y la no tratada con anticoagulantes. Estudio AFABE 2013 ·Revista Española de Cardiología ·Josep Lluís Clua‐Espuny, (unknown), Ramón Bosch, Albert Roso‐Llorach, (unknown), (unknown), Carlos López, (unknown), (unknown), Núria González-Rojas, (unknown)	61
8	Costs in Patients Along First Year Poststroke in Spain 2013 ·Value in Health ·(unknown), Jaime Masjuán, Miguel Casado, Javier Mar, (unknown), Núria González-Rojas	1
9	Análisis coste-efectividad de dabigatrán para la prevención de ictus y embolia sistémica en fibrilación auricular no valvular en España 2012 ·Revista Española de Cardiología ·José Ramón González‐Juanatey, José Álvarez‐Sabín, José María Lobos, Antoni Martínez‐Rubio, Joan Carles Reverter, Itziar Oyagüez, Núria González-Rojas, Virginia Becerra	55
10	Cost-effectiveness of Dabigatran for Stroke Prevention in Non-valvular Atrial Fibrillation in Spain 2012 ·Revista Española de Cardiología (English Edition) ·José Ramón González‐Juanatey, José Álvarez‐Sabín, José María Lobos, Antoni Martínez‐Rubio, Joan Carles Reverter, Itziar Oyagüez, Núria González-Rojas, Virginia Becerra	60
11	Validación de la versión traducida del Chronic Obstructive Pulmonary Disease-Population Screener (COPD-PS). Su utilidad y la del FEV1/FEV6 para el diagnóstico de enfermedad pulmonar obstructiva crónica 2011 ·Medicina Clínica ·Marc Miravitlles, Carl Llor, (unknown), Silvia Díaz‐Cerezo, Helena Díaz-Cuervo, Núria González-Rojas	21
12	Treatment patterns, use of resources, and costs of advanced non-small-cell lung cancer patients in Spain: results from a Delphi panel 2011 ·Clinical & Translational Oncology ·Dolores Isla, Núria González-Rojas, (unknown), Max Brosa, Henrik W. Finnern	29
13	Análisis de coste-efectividad de tiotropio en el tratamiento de la EPOC en España 2010 ·Max Brosa, Silvia Díaz‐Cerezo, Marc Miravitlles, Núria González-Rojas, (unknown)	0
14	An economic analysis of pharmacological treatment of COPD in Spain 2009 ·Respiratory Medicine ·Marc Miravitlles, Max Brosa, (unknown), Carlos Crespo, Elena Gobartt, Silvia Díaz‐Cerezo, Núria González-Rojas	21
15	PRS22 COST-EFFECTIVENESS ANALYSIS OF TIOTROPIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS IN SPAIN. 2009 ·Value in Health ·Max Brosa, Silvia Díaz‐Cerezo, Marc Miravitlles, Núria González-Rojas, (unknown)	2
16	Análisis económico de dabigatrán etexilato en prevención primaria del tromboembolismo venoso tras artroplastia total de cadera o rodilla 2009 ·M. Monreal, Núria González-Rojas, (unknown), Sorrel Wolowacz	16
17	PMS38 ECONOMIC ANALYSIS OF DABIGATRAN ETEXILATE FOR THE PRIMARY PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP OR KNEE REPLACEMENT IN SPAIN 2009 ·Value in Health ·Núria González-Rojas, (unknown), M. Monreal, (unknown)	3
18	Epidemiology and Costs of Screening and Management of Precancerous Lesions of the Cervix in Spain 2008 ·Journal of Lower Genital Tract Disease ·Xavier Castellsagué, Vanessa Rémy, Luis M. Puig‐Tintoré, Ricardo Sáinz de la Cuesta, Núria González-Rojas, Catherine Cohet	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact